Dr. Hussain Abde Ali Karimi, MD

Dr. Karimi practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Karimi's NPI, 1477039972, was assigned on July 17, 2018. Dr. Karimi holds Pennsylvania license NIT222318.

Dr. Karimi's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Karimi's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Karimi is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Karimi to 5 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karimi practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Karimi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Karimi's licenses on file in 2 states: Pennsylvania and Ohio.

CMS data shows 335 Medicare services from Dr. Karimi across 4 procedure codes in 2024, for 150 Medicare patients. Medicare paid $24,286 for them.

CMS counts 150 Medicare patients who saw Dr. Karimi in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 3.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karimi's median patient age at 70, with 36% women.

In 2024, Dr. Karimi wrote 1,180 Medicare Part D claims for 184 patients. 78% of them were for generic drugs. CMS names the drug for 1,025 of them, across 28 drugs with 11 or more claims each, at $249,224 in total drug cost. In 2023, CMS named 113 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Karimi for performance year 2024, reported as part of a group. Dr. Karimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karimi as offering telehealth.

Dmand AI links 3 papers to Dr. Karimi, published from 2020 to 2022. Dr. Karimi has published most often in Cureus. Dr. Karimi's most frequent co-authors are Gautam Vinod Shah, MD and Leslie Brandon Tolle, MD.

CMS Open Payments shows 41 general payments to Dr. Karimi from 12 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $411.